| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/25/2013 | CA2852960A1 Antigen presenting cancer vaccine with gamma interferon |
| 04/25/2013 | CA2852942A1 Method of treating or reducing efp |
| 04/25/2013 | CA2852917A1 Amine cationic lipids and uses thereof |
| 04/25/2013 | CA2852874A1 Compositions comprising alkaline phosphatase and/or natriuretic peptide and methods of use thereof |
| 04/25/2013 | CA2852683A1 Methods and compositions for treating ineffective erythropoiesis |
| 04/25/2013 | CA2852594A1 Peptide compounds derived from melanotransferrin and uses thereof |
| 04/25/2013 | CA2852469A1 Codon signature for neuromyelitis optica |
| 04/25/2013 | CA2852468A1 Peptidomimetic macrocyles |
| 04/25/2013 | CA2852454A1 Aromatic-cationic peptides and uses of same |
| 04/25/2013 | CA2852397A1 Use of sulfated glycosaminoglycans for improving the bioavailability of factor viii |
| 04/25/2013 | CA2851288A1 Stabilizers for hemostatic products |
| 04/25/2013 | CA2851286A1 Method of forming hemostatic products |
| 04/25/2013 | CA2851144A1 Novel plant defensins and use in the treatment of proliferative diseases |
| 04/25/2013 | CA2851057A1 Combined use of a sulfated glycosaminoglycan and a hyaluronidase for improving the bioavailability of factor viii |
| 04/25/2013 | CA2850579A1 Method for improving the stability of purified factor viii after reconstitution |
| 04/24/2013 | EP2583977A1 Retinol-modified collagen, method for producing same, and external composition for skin containing same |
| 04/24/2013 | EP2583693A1 Pharmaceutical composition utilizing pancreatic cell proliferation factor |
| 04/24/2013 | EP2583687A1 Use of botulinum toxin for treating hyperhydrosis |
| 04/24/2013 | EP2583686A1 Agent for reducing acetaldehyde in oral cavity |
| 04/24/2013 | EP2583685A1 Method of administering and using VEGF inhibitors for the treatment of human cancer |
| 04/24/2013 | EP2583684A2 Peptide having antimicrobial or anti-inflammatory activity and pharmaceutical composition containing same as an active ingredient |
| 04/24/2013 | EP2583675A1 Use of dipeptidylpeptidase inhibitors to regulate glucose metabolism |
| 04/24/2013 | EP2582814A2 Phage-gnrh constructs, their mimics, antigenic compositions, and sequences for immunocontraception of animals and other applications |
| 04/24/2013 | EP2582719A2 Single chain insulin agonists exhibiting high activity at the insulin receptor |
| 04/24/2013 | EP2582715A2 Growth hormone secretatogue receptor antagonists and uses thereof |
| 04/24/2013 | EP2582682A1 Methods of treating lung disease |
| 04/24/2013 | EP2582396A2 Long lasting drug formulations |
| 04/24/2013 | EP2582394A1 Stabilised human immunoglobulin composition |
| 04/24/2013 | EP2582388A2 Detection of epha3 as a marker of the presence of a solid tumor |
| 04/24/2013 | EP2582387A2 Compositions and methods for treating inflammatory conditions |
| 04/24/2013 | EP2582386A2 Il-10 and methods of treating ocular and other diseases |
| 04/24/2013 | EP2582385A1 Treatment of vascular complications of diabetes |
| 04/24/2013 | EP2582384A2 Compositions and methods for treating cancer |
| 04/24/2013 | EP2582383A2 Innate defence regulatory peptide compositions for treatment of arthritis |
| 04/24/2013 | EP2582382A2 Therapeutic and cosmetic uses and applications of calreticulin |
| 04/24/2013 | EP2582381A1 Novel formulations and methods |
| 04/24/2013 | EP2582380A1 Comparison of protein samples |
| 04/24/2013 | EP2582379A2 Compositions and methods for the treatment of atherosclerosis |
| 04/24/2013 | CN1869061B Peptidomimetic protease inhibitors |
| 04/24/2013 | CN1788017B Differentially expressed nucleic acids in the blood-brain barrier under inflammatory conditions |
| 04/24/2013 | CN1741812B Modified hemoglobin and methods of making same |
| 04/24/2013 | CN1630527B Methods and compositions for oxygen transport comprising a high oxygen affinity |
| 04/24/2013 | CN1552734B Recombination glant associated virus carrier induced TNF concerned cytonecrosis ligand peptide fragment and its use |
| 04/24/2013 | CN1535141B Sustained-release composition and process for producing the same |
| 04/24/2013 | CN1520303B Turnor therapy with alphavirus-based and high affinity laminin receptor-targeted vectors |
| 04/24/2013 | CN103068845A Factor xii inhibitors for treating interstitial lung disease |
| 04/24/2013 | CN103068844A Retinol-modified collagen, method for producing same, and external composition for skin containing same |
| 04/24/2013 | CN103068843A Fibronectin based scaffold domain proteins that bind pcsk9 |
| 04/24/2013 | CN103068842A Single chain insulin agonists exhibiting high activity at the insulin receptor |
| 04/24/2013 | CN103068841A 胰高血糖素类似物 Glucagon analogs |
| 04/24/2013 | CN103068840A Antimicrobial peptide variants and polynucleotides encoding same |
| 04/24/2013 | CN103068839A Improved recombinant human follicle-stimulating hormone |
| 04/24/2013 | CN103068401A Method of treatment |
| 04/24/2013 | CN103068400A Glycoproteins having lipid mobilizing properties and therapeutic uses thereof |
| 04/24/2013 | CN103068399A Polypeptides and uses thereof as a drug for treatment of multiple sclerosis, rheumatoid arthritis and other autoimmune disorders |
| 04/24/2013 | CN103068369A Method for producing a lipid particle, the lipid particle itself and its use |
| 04/24/2013 | CN103068368A Method for producing a lipid particle, the lipid particle itself and its use |
| 04/24/2013 | CN103068366A A liquid formulation of long-acting human growth hormone conjugate |
| 04/24/2013 | CN103068365A Removal of serine proteases by treatment with finely divided silicon dioxide |
| 04/24/2013 | CN103060335A Optimization and high-efficiency expression of insulin aspart precursor gene |
| 04/24/2013 | CN103060324A Multiple promoter expression cassettes for simultaneous delivery of rnai agents |
| 04/24/2013 | CN103060299A L-asparaginase variant with increased activity |
| 04/24/2013 | CN103059127A GLP-1 analogs, and preparation method and application thereof |
| 04/24/2013 | CN103059124A Recombined porcine interferon Gamma, coding gene thereof and expressing method |
| 04/24/2013 | CN103059123A Recombinant porcine interferon beta1, encoding gene and expression method thereof |
| 04/24/2013 | CN103059122A Recombined porcine interferon alpha 1, as well as gene encoding gene and expression method thereof |
| 04/24/2013 | CN103059106A Polymixin derivative and application thereof |
| 04/24/2013 | CN103059102A Polypeptide for inhibiting hepatitis C viruses (HCVs) from infecting cells, and its application |
| 04/24/2013 | CN103059100A New peptides useful as dual caspase-2/-6 inhibitor and biological application thereof |
| 04/24/2013 | CN103059099A Novel pidotimod crystal form and preparation method thereof |
| 04/24/2013 | CN103058236A Nanoscale peptide drugs controlled release carrier layered double hydroxides (LDHs) and preparation and application thereof |
| 04/24/2013 | CN103058159A Hollow hierarchical hydroxyapatite microspheres and preparation method and application thereof |
| 04/24/2013 | CN103055326A Application of TCRP1 gene in the preparation of tumor cell platinum resistance reversal agent |
| 04/24/2013 | CN103055307A Injection composed of minocycline micro-capsule and lysozyme micro-capsule and used for treating periodontal disease |
| 04/24/2013 | CN103055306A Diagnosis and treatment of multiple sulfatase deficiency and other sulfatase deficiencies |
| 04/24/2013 | CN103055305A A lyophilized preparation of a cytochrome C-containing pharmaceutical composition for injection and a preparation method thereof |
| 04/24/2013 | CN103055304A Compound temperature-sensitive gel for treating skin ulcer and preparation method thereof |
| 04/24/2013 | CN103055303A Composition capable of promoting differentiation of autologous preadipocytes and formation of lipid droplets and preparation method thereof |
| 04/24/2013 | CN103055302A Ultrasonic biological effect mediated recombinant human endostatin controlled release preparation |
| 04/24/2013 | CN103055301A Application of angiotensin II improving the ability of mesenchymal stem cells to repair myocardial ischemia injury |
| 04/24/2013 | CN103055011A G6 lectin extracted from traditional Chinese medicines and applications thereof in detoxification, pressure stabilization, blood vessel softening and complication resistance |
| 04/24/2013 | CN103054816A Aprotinin freeze-dried powder and preparation method thereof |
| 04/24/2013 | CN103054812A Growth factor controlled-release micro-sphere with thermo-sensitive switch and preparation method thereof |
| 04/24/2013 | CN103054811A Preparation method for biodegradable micro-particles containing drugs |
| 04/24/2013 | CN103054796A Cyclosporine A micelle eye drop and preparing method thereof |
| 04/24/2013 | CN102389571B Medicine sustained-release suppository used for in-vivo injection |
| 04/24/2013 | CN102337268B Human CTRP4 gene, its coding protein and their application |
| 04/24/2013 | CN102302767B Novel extraction method of cerebroprotein hydrolysate solution |
| 04/24/2013 | CN102286081B Aspirin modified peptide nucleic acid oligomer and preparation method and application thereof |
| 04/24/2013 | CN102250223B Molecular improved apoptin (30-121) as well as preparation method and application thereof |
| 04/24/2013 | CN102202674B Multilayered blood product |
| 04/24/2013 | CN102188704B Methods of treating cancer using IL-21 and monoclonal antibody therapy |
| 04/24/2013 | CN102127146B Method for preparing atosiban acetate |
| 04/24/2013 | CN102106828B Thymalfasin sustained-release microsphere preparation and preparation method thereof |
| 04/24/2013 | CN102100904B Reduced glutathione percutaneous absorption preparation and preparation method thereof |
| 04/24/2013 | CN102077901B Swine hemoglobin enzymolysis and decoloration method |
| 04/24/2013 | CN102000323B Application of SJ16 protein in preparing immunosuppressive drugs |
| 04/24/2013 | CN101985468B SJ16 recombinant protein and application thereof in preparing schistosomiasis vaccine, diagnostic reagent and therapeutic drug |
| 04/24/2013 | CN101979093B Composition comprising polypeptide-drug substance and other poorly absorbed active ingredient and its use |
| 04/24/2013 | CN101974073B Anti-inflammatory hexapeptide |